CEO E. Rand Sutherland was paid $4,302,100 in fiscal year 2025, ↓ down 52.8% from fiscal year 2024 (SEC filing 0001193125-26-158966 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$4,302,100 ↓ E. Rand Sutherland total, FY2025 | — CEO pay percentile vs peers | — CEO-to-median pay ratio | — Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
UPB's next annual pay disclosure, estimated April 16, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| E. Rand Sutherland | $650,000 | $0 | $0 | $3,300,350 | $341,250 | $0 | $10,500 | $4,302,100 |
| Chief Executive Officer | ||||||||
| Michael Paul Gray | 490,000 | 0 | 0 | 1,287,137 | 205,800 | 0 | 10,500 | 1,993,437 |
| Chief Financial Officer and Chief Operating Officer | ||||||||
| Aaron Deykin | 515,000 | 0 | 0 | 1,089,116 | 216,300 | 0 | 10,500 | 1,830,916 |
| Chief Medical Officer and Head of Research and Development | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| E. Rand Sutherland | $4,302,100 | $9,108,953 | — | ↓ −4,806,853 |
| Michael Paul Gray | 1,993,437 | 2,938,577 | — | ↓ −945,140 |
| Aaron Deykin | 1,830,916 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Upstream Bio, Inc.'s Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper UPB reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
Get the Upstream Bio, Inc. Peer Teardown Report
$4,302,100 E. Rand Sutherland total, FY2025
$199
The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.
Data as of September 17, 2026 · Source: 0001193125-26-158966 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
Reports for UPB
Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:
Order UPB
Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.
How we handle your data → Privacy
The list of companies that name UPB as a peer is temporarily unavailable — recheck shortly.
Get the Upstream Bio, Inc. Executive Compensation Report
$1,500
One page per officer: the same table above, read for one person at a time — his own figure and every fiscal year the register holds.
| Executive | Role | FY2025 total |
|---|---|---|
| Aaron Deykin | Executive | $1,830,916 |
| E. Rand Sutherland | CEO | $4,302,100 |
| Michael Paul Gray | CFO | $1,993,437 |
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Daniella Beckman | Independent Director | $204,010 |
| Erez Chimovits | Independent Director | $196,810 |
| H. Edward Fleming, Jr | Independent Director | — |
| Liam Ratcliffe | Independent Director | $202,510 |
| Marcella Kuhlman Ruddy | Independent Director | $199,010 |
| Ronald C. Renaud, Jr | Chair of the Board | — |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| H. Edward Fleming Jr | Director | 2026-06-09 | A | 17,096 | $0 | $0 | Derivative, Class A Common | Form 4 ↗ |
| Daniella Beckman | Director | 2026-06-09 | A | 17,096 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Marcella Kuhlman Ruddy | Director | 2026-06-09 | A | 17,096 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Liam Ratcliffe | Director | 2026-06-09 | A | 17,096 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ronald C. Renaud Jr | Director | 2026-06-09 | A | 17,096 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Erez Chimovits | Director | 2026-06-09 | A | 17,096 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Paul Gray | CFO and COO | 2026-06-16 | D | 853 | 6 | 5,203 | Common | Form 4 ↗ |
| Allison Ambrose | General Counsel | 2026-06-16 | D | 477 | 6 | 2,910 | Common | Form 4 ↗ |
| Aaron Deykin | Chief Medical Officer | 2026-06-16 | D | 895 | 6 | 5,460 | Common | Form 4 ↗ |
| Adam Houghton | Chief Business Officer | 2026-06-16 | D | 700 | 6 | 4,270 | Common | Form 4 ↗ |
| E. Rand Sutherland | Director | 2026-06-16 | D | 2,095 | 6 | 12,780 | Common | Form 4 ↗ |
| Adam Houghton | Chief Business Officer | 2026-09-16 | D | 700 | 5 | 3,843 | Common | Form 4 ↗ |
| E. Rand Sutherland | Director | 2026-09-16 | D | 2,095 | 5 | 11,502 | Common | Form 4 ↗ |
| Aaron Deykin | Chief Medical Officer | 2026-09-16 | D | 895 | 5 | 4,914 | Common | Form 4 ↗ |
| Allison Ambrose | General Counsel | 2026-09-16 | D | 485 | 5 | 2,663 | Common | Form 4 ↗ |
| Michael Paul Gray | CFO and COO | 2026-09-16 | D | 853 | 5 | 4,683 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| E. Rand Sutherland | OPTION | 2025-02-06 | — | — | 500,000 | — | $3,300,350 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| E. Rand Sutherland | $0 | $0 | $3,300,350 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| E. Rand Sutherland | Option | 505,578 | 5.69 | — |
| Aaron Deykin | Option | 53,210 | 3.45 | — |
| E. Rand Sutherland | Option | 614,717 | 6.59 | — |
| Michael Paul Gray | Option | 250,335 | 5.69 | — |
| E. Rand Sutherland | Option | 395,834 | 8.53 | — |
| Michael Paul Gray | Option | 154,375 | 8.53 | — |
| Aaron Deykin | Option | 130,625 | 8.53 | — |
| Aaron Deykin | Option | 5,081 | 4.27 | — |
| Michael Paul Gray | Option | 88,930 | 5.69 | — |
| Aaron Deykin | Option | 23,305 | 3.45 | — |
| Aaron Deykin | Option | 4,939 | 4.87 | — |
| Aaron Deykin | Option | 64,772 | 6.59 | — |
Our executive compensation philosophy is to provide a competitive and market-based total compensation program to attract, motivate, and retain our executive team. Our compensation is based heavily on performance, which aligns with our goal to drive long-term growth and value creation.
| CEO STI target (% of salary) | 50% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Alpine Rewards |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Ronald C. Renaud JrIndependent · Board Chair · Compensation (Chair) | $82,000 | $0 | $149,010 | $0 | $0 | $231,010 |
| Daniella BeckmanIndependent · Audit (Chair) | 55,000 | 0 | 149,010 | 0 | 0 | 204,010 |
| Liam RatcliffeIndependent · Audit · Compensation | 53,500 | 0 | 149,010 | 0 | 0 | 202,510 |
| H. Edward Fleming JrIndependent · Audit · Nominating/Governance | 52,500 | 0 | 149,010 | 0 | 0 | 201,510 |
| Marcella Kuhlman RuddyIndependent · Nominating/Governance (Chair) | 50,000 | 0 | 149,010 | 0 | 0 | 199,010 |
| Erez ChimovitsIndependent · Nominating/Governance · Compensation | 47,800 | 0 | 149,010 | 0 | 0 | 196,810 |
| E. Rand SutherlandEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 12,000 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $340,800 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $340,800 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Upstream Bio, Inc. | 2025 | E. Rand Sutherland | $650,000 | $0 | $3,300,350 | $341,250 | $4,302,100 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, E. Rand Sutherland | DEF 14A | 2026-04-16 | 0001193125-26-158966 | Section “Executive Compensation”. As printed: 4,302,100. Filing ↗machine: r2 · c24 · span 433625–433634 |
| 2 | Section 01, Michael Paul Gray | DEF 14A | 2026-04-16 | 0001193125-26-158966 | Section “Executive Compensation”. As printed: 1,993,437. Filing ↗machine: r4 · c24 · span 452063–452072 |
| 3 | Section 01, Aaron Deykin | DEF 14A | 2026-04-16 | 0001193125-26-158966 | Section “Executive Compensation”. As printed: 1,830,916. Filing ↗machine: r6 · c24 · span 470912–470921 |
| 4 | Section 03, E. Rand Sutherland OPTION | DEF 14A | 2026-04-16 | 0001193125-26-158966 | Section “EXE CUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t10 · r2 · c9 · span 428437–428446 |
| 5 | Section 07, pay ratio | 10-K | 2026-03-26 | 0001193125-26-126188 | Section “CEO Pay Ratio”. As printed: —. Filing ↗ |
| 6 | Section 08, Ronald C. Renaud Jr | DEF 14A | 2026-04-16 | 0001193125-26-158966 | Section “Director Compensation”. As printed: 231,010. Filing ↗machine: span 324819–325028 |
| 7 | Section 08, Daniella Beckman | DEF 14A | 2026-04-16 | 0001193125-26-158966 | Section “Director Compensation”. As printed: 204,010. Filing ↗ |
| 8 | Section 08, Liam Ratcliffe | DEF 14A | 2026-04-16 | 0001193125-26-158966 | Section “Director Compensation”. As printed: 202,510. Filing ↗machine: span 345579–345788 |
| 9 | Section 08, H. Edward Fleming Jr | DEF 14A | 2026-04-16 | 0001193125-26-158966 | Section “Director Compensation”. As printed: 201,510. Filing ↗machine: span 338675–338884 |
| 10 | Section 08, Marcella Kuhlman Ruddy | DEF 14A | 2026-04-16 | 0001193125-26-158966 | Section “Director Compensation”. As printed: 199,010. Filing ↗machine: span 331783–331992 |
| 11 | Section 08, Erez Chimovits | DEF 14A | 2026-04-16 | 0001193125-26-158966 | Section “Director Compensation”. As printed: 196,810. Filing ↗ |
| 12 | Section 08, E. Rand Sutherland | DEF 14A | 2026-04-16 | 0001193125-26-158966 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 13 | Section 02, H. Edward Fleming Jr 2026-06-09 | Form 4 | 2026-06-11 | 0001193125-26-268167 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 14 | Section 02, Daniella Beckman 2026-06-09 | Form 4 | 2026-06-11 | 0001193125-26-268166 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 15 | Section 02, Marcella Kuhlman Ruddy 2026-06-09 | Form 4 | 2026-06-11 | 0001193125-26-268169 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 16 | Section 02, Liam Ratcliffe 2026-06-09 | Form 4 | 2026-06-11 | 0001193125-26-268165 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 17 | Section 02, Ronald C. Renaud Jr 2026-06-09 | Form 4 | 2026-06-11 | 0001193125-26-268168 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 18 | Section 02, Erez Chimovits 2026-06-09 | Form 4 | 2026-06-11 | 0001193125-26-268164 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 19 | Section 02, Michael Paul Gray 2026-06-16 | Form 4 | 2026-06-17 | 0001193125-26-274126 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 20 | Section 02, Allison Ambrose 2026-06-16 | Form 4 | 2026-06-17 | 0001193125-26-274119 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 21 | Section 02, Aaron Deykin 2026-06-16 | Form 4 | 2026-06-17 | 0001193125-26-274121 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 22 | Section 02, Adam Houghton 2026-06-16 | Form 4 | 2026-06-17 | 0001193125-26-274122 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 23 | Section 02, E. Rand Sutherland 2026-06-16 | Form 4 | 2026-06-17 | 0001193125-26-274125 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 24 | Section 02, Adam Houghton 2026-09-16 | Form 4 | 2026-09-17 | 0001193125-26-394324 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, E. Rand Sutherland 2026-09-16 | Form 4 | 2026-09-17 | 0001193125-26-394325 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Aaron Deykin 2026-09-16 | Form 4 | 2026-09-17 | 0001193125-26-394330 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Allison Ambrose 2026-09-16 | Form 4 | 2026-09-17 | 0001193125-26-394318 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, Michael Paul Gray 2026-09-16 | Form 4 | 2026-09-17 | 0001193125-26-394322 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 30 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 31 | Section 09b board cost (computed) | Computed | — | — | Cash 340,800 + equity 0 + all other 0 = 340,800, summed across the director compensation table rows.machine: formula: Σ = 340,800 |
| 32 | Upstream Bio, Inc. (subject), Section 10b CEO total | DEF 14A | 2026-04-16 | 0001193125-26-158966 | CEO total compensation as printed in Upstream Bio, Inc.'s own proxy. As printed: 4,302,100. Filing ↗machine: r2 · c24 · span 433625–433634 |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.
Get the Upstream Bio, Inc. Executive Compensation Report
$1,500